Treatment approaches for dual diagnosis clients in England

References

• Drake R, Osher F, Wallach M. Alcohol use and abuse in schizophrenia; a prospective community study. J Nerv Ment Dis 1989; 177: 408–14
   PubMed Web of Science ®Google Scholar
• Regier D A, Farmer M E, Rae D S, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990; 264: 2511–18
   PubMed Web of Science ®Google Scholar
• Mueser K, Bellack A, Blanchard J. Comorbidity of schizophrenia and substance abuse. J Clin Chiropract Pediatr 1992; 60: 845–56
   Google Scholar
• Kendler K S, Davis C G, Kessler R C. The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history. Br J Psychiatry 1997; 170: 541–8
   PubMed Web of Science ®Google Scholar
• Bartu A, Freeman N, Gawthorne G, Codde J, Holman C DJ. Psychiatric comorbidity in a cohort of heroin and amphetamine users in Perth, Western Australia. J Subst Use 2003; 8: 150–4
   Google Scholar
• Margolese H C, Malchy L, Negrete J C, Tempier R, Gill K. Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophr Res 2004; 67: 157–66
   PubMed Web of Science ®Google Scholar
• Bakken K, Landheim A S, Vaglum P. Substance-dependent patients with and without social anxiety disorder: occurrence and clinical differences: a study of a consecutive sample of alcohol-dependent and poly-substance-dependent patients treated in two counties in Norway. Drug Alcohol Depend 2005; 80: 321–8
   PubMed Web of Science ®Google Scholar
• Duke P, Pantelis C, Barnes T. South Westminster schizophrenia survey. Alcohol use and its relationship to symptoms, tardive dyskinesia and illness onset. Br J Psychiatry 1994; 164: 630–36
   PubMed Web of Science ®Google Scholar
• Menezes P, Johnson S, Thornicroft G, et al. Drug and alcohol problems among individuals with severe mental illness in south London. Br J Psychiatry 1996; 168: 612–19
   PubMed Web of Science ®Google Scholar
• Crome I. Overview: psychiatric comorbidity and substance misuse: what are the issues?. Drugs Educ Prev Policy 1999; 6: 149–50
   Web of Science ®Google Scholar
• Afuwape S. Where are we with dual diagnosis (substance misuse and mental illness)? A review of the literature. Rethink, London 2003
   Google Scholar
• Drake R, Osher F, Wallach M. Alcohol use and abuse in schizophrenia; a prospective community study. J Nerv Ment Dis 1989; 177: 408–14
   PubMed Web of Science ®Google Scholar
• Linszen D, Dingemans P, Lenior M. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994; 51: 273–79
   PubMed Web of Science ®Google Scholar
• Scott H, Johnson S, Menezes P, et al. Substance misuse and risk of aggression and offending among the severely mentally ill. Br J Psychiatry 1998; 172: 345–50
   PubMed Web of Science ®Google Scholar
• Kamali M, Kelly L, Gervin M, Browne S, Larkin C, O'Callaghan E. The prevalence of comorbid substance misuse and its influence on suicidal ideation among in patients with schizophrenia. Acta Psychiatr Scand 2000; 101: 452–56
   PubMed Web of Science ®Google Scholar
• Johnson J. Cost-effectiveness of mental health services for persons with a dual diagnosis: a literature review and the CCMHCP. J Subst Abuse Treat 2000; 18: 119–28
   PubMed Web of Science ®Google Scholar
• Drake R, Mueser K. Psychosocial approaches to dual diagnosis. Schizophr Bull 2000; 26: 105–18
   PubMed Web of Science ®Google Scholar
• Drake R, Mercer-McFadden C, Mueser K, McHugo G, Bond G. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull 1998; 24: 589–608
   PubMed Web of Science ®Google Scholar
• Jeffery D P, Ley A, McLaren S, Siegfried N. Psychosocial treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2000, 2, CD001088. DOI: 10.1002/14651858.CD001088
   Google Scholar
• Donald M, Dower J, Kavanagh D. Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials. Soc Sci Med 2005; 60: 1371–83
   PubMed Web of Science ®Google Scholar
• Tiet Q, Mausbach B. Treatments for patients with dual diagnosis: a review. Alcohol Clin Exp Res 2007; 31: 513–36
   PubMed Web of Science ®Google Scholar
• Phillips P, Johnson S. Drug and alcohol misuse among in-patients with psychotic illnesses in three inner-London psychiatric units. Psychiatr Bull 2003; 27: 217–20
   Google Scholar
• Barnes T, Mutsatsa S, Hutton S, Watt H, Joyce E. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry 2006; 188: 237–42
   PubMed Web of Science ®Google Scholar
• Duke P, Pantelis C, McPhillips M, Barnes T. Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London. Br J Psychiatry 2001; 179: 509–13
   PubMed Web of Science ®Google Scholar
• Holland M. How substance use affects people with mental illness. Nurs Times 1999; 95: 46–48
   PubMedGoogle Scholar
• Wright S, Gournay K, Glorney E, Thornicroft G. Dual diagnosis in the suburbs: prevalence, need, and in-patient service use. Soc Psychiatry Psychiatr Epidemiol 2000; 35: 297–304
   PubMed Web of Science ®Google Scholar
• Graham H, Maslin J, Copello A, et al. Drug and alcohol problems amongst individuals with severe mental health problems in an inner city area of the UK. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 448–55
   PubMed Web of Science ®Google Scholar
• Virgo N, Bennett G, Higgins D, Bennett L, Thomas P. The prevalence and characteristics of co-occurring serious mental illness (SMI) and substance abuse or dependence in the patients of Adult Mental Health and Addictions Services in eastern Dorset. J Ment Health 2001; 10: 175–88
   Google Scholar
• Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M. Psychiatric symptoms among clients seeking treatment for drug dependence: intake data from the National Treatment Outcome Research Study. Br J Psychiatry 2000; 176: 285–9
   PubMed Web of Science ®Google Scholar
• Weaver T, Hickman M, Rutter D, Ward J, Stimson G, Renton A. The prevalence and management of co-morbid substance misuse and mental illness: results of a screening survey in substance misuse and mental health treatment populations. Drug Alcohol Rev 2001; 20: 407–16
   Web of Science ®Google Scholar
• Strathdee G, Manning V, Best D, et al. Dual diagnosis in a primary care group (PCG): a step-by-step epidemiological needs assessment and design of a training and service response model. Department of Health, London 2002
   Google Scholar
• Ley A, Jeffrey D, Ruiz J, McLaren S, Gillespie C. Underdetection of comorbid drug use in acute psychatric admission. Psychiatr Bull 2002; 26: 248–51
   Google Scholar
• Tarrier N, Sommerfield C. Alcohol and substance use in civilian chronic PTSD patients seeking psychological treatment. J Subst Use 2003; 8: 197–204
   Google Scholar
• Mueser K, Drake R, Wallach M. Dual diagnosis: a review of etiological theories. Addict Behav 1998; 23: 717–34
   PubMed Web of Science ®Google Scholar
• MacGregor S. Messages and findings from the Department of Health drugs misuse research initiative: final overview report. Drugs Educ Prev Policy 2005; 12: 1–136
   Web of Science ®Google Scholar
• Crawford V, Crome I, Clancy C. Co-existing problems of mental health and substance misuse (dual diagnosis): a literature review. Drugs Educ Prev Policy 2003; 10: 1–74
   Web of Science ®Google Scholar
• Graham H, Copello A, Birchwood M, et al. Service innovations: coexisting severe mental health and substance use problems: developing integrated services in the UK. Psychiatr Bull 2003; 27: 183–6
   Google Scholar
• Gonzales J, Insel T. The conundrum of co-occurring mental and substance use disorders: opportunities for research. Biol Psychiatry 2004; 56: 723–5
   PubMed Web of Science ®Google Scholar
• Kay-Lambkin F, Baker A, Lewin T. The ‘co-morbidity roundabout’: a framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems. Drug Alcohol Rev 2004; 23: 407–23
   PubMed Web of Science ®Google Scholar
• Lowe A, Abou-Saleh M. The British experience of dual diagnosis in the national health service. Acta Neuropsychiatry 2004; 16: 41–46
   PubMed Web of Science ®Google Scholar
• Minkoff K. An integrated model for the management of co-occurring psychiatric and substance disorders in managed-care systems. Dis Manage Health Outcomes 2000; 8: 251–7
   Google Scholar
• Health Advisory Service. Substance misuse and mental health co-morbidity (dual diagnosis). Standards for mental health services. Health Advisory Service, London 2001
   Google Scholar
• Department of Health. Mental health policy implementation guide: dual diagnosis good practice guide. Department of Health, London 2002
   Google Scholar
• National Treatment Agency of Substance Misuse. Models of care for the treatment of drug misusers. Part 2: Full reference report. National Treatment Agency for Substance Misuse, London 2002
   Google Scholar
• Barreira P, Espey B, Fishbein R, Moran D, Flannery R. Linking substance abuse and serious mental illness service delivery systems: initiating a statewide collaborative. J Behav Health Serv Res 2000; 27: 107–13
   PubMed Web of Science ®Google Scholar
• Grella C, Gilmore J. Improving service delivery to the dually diagnosed in Los Angeles County. J Subst Abuse Treat 2002; 23: 115–22
   PubMed Web of Science ®Google Scholar
• Gil-Rivas V, Grella C. Addictions services treatment services and service delivery models for dually diagnosed clients: variations across mental health and substance abuseproviders. Commun Ment Health J 2005; 41: 251–66
   PubMed Web of Science ®Google Scholar
• Moggi F, Ouimette P, Moos R, Finney J. Dual diagnosis patients in substance abuse treatment: relationship of general coping and substance-specific coping to 1-year outcomes. Addiction 1999; 94: 1805–16
   PubMed Web of Science ®Google Scholar
• Drake R, Morse G, Brunette M, Torrey W. Evolving U.S. service model for patients with severe mental illness and co-occurring substance use disorder. Acta Neuropsychiatry 2004; 16: 36–40
   PubMed Web of Science ®Google Scholar
• Martino S, Carroll K, Nich C, Rounsaville B. A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction 2006; 101: 1479–92
   PubMed Web of Science ®Google Scholar
• Appleby L. The national service framework for mental health—five years on. Department of Health, London 2004
   Google Scholar
• Ley A, Jeffery D, McLaren S, Siegfried N. Treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev 2006; 36(2), CD001088
   Google Scholar
• Available at: http://drugscope.soutron.com/helpfinder.asp (accessed 5 December 2005)
   Google Scholar
• Drugscope. Drug problems: where to get help. Directory of services. DrugScope, London 2002
   Google Scholar
• Available at: http://talktofrank.com/home_html.aspx (accessed 5 December 2005)
   Google Scholar
• Day E, Ison J, Keaney F, Buntwal N, Strang J. A national survey of inpatient drug treatment services in England. National Treatment Agency, London 2005
   Google Scholar
• SPSS, Inc. SPSS for Windows, version 12.0.1. SPSS, Chicago, IL 2001
   Google Scholar
• Weber R P. Basic Content Analysis2nd edn. Sage publications, Newbury Park, CA 1990
   Google Scholar
• Mathers D, Ghodse A, Caan A, Scott S. Cannabis use in a large sample of acute psychiatric admissions. Br J Addict 1991; 86: 779–84
   PubMedGoogle Scholar
• Weaver T, Madden P, Charles V, et al. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry 2003; 183: 304–13
   PubMed Web of Science ®Google Scholar
• Kidorf M, Disney E R, King V L, Neufeld K, Beilenson B L, Brooner R K. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug Alcohol Depend 2004; 74: 115–22
   PubMed Web of Science ®Google Scholar
• Bauer M S, Altshuler L, Evans D R, Beresford T, Williford T E, Hauger R. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. J Affect Disord 2005; 85: 301–15
   PubMed Web of Science ®Google Scholar
• Rush A J, Zimmermann M, Wisniewski S R, et al. Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features. J Affect Disord 2005; 87: 43–45
   PubMed Web of Science ®Google Scholar
• Soyka M, Albus M, Immler B, Kathmann N, Hippius H. Psychopathology in dual-diagnosis and nonaddicted schizophrenics: are there differences?. Eur J Health Econ 2002; 3: 114–20
   Google Scholar
• Gual A. Dual diagnosis in Spain. Drug Alcohol Rev 2007; 26: 65–71
   PubMed Web of Science ®Google Scholar
• Hides L, Dawe S, Young R, Kavanagh D. The reliability and validity of the Severity of Dependence Scale for detecting cannabis dependence in psychosis. Addiction 2007; 102: 35–40
   PubMed Web of Science ®Google Scholar
• Phillips P. The mad, the bad and the dangerous—harm reduction in dual diagnosis. Int J Drug Policy 1998; 9: 345–9
   Google Scholar
• Brown V, Melchior L, Huba G. Level of burden among women diagnosed with severe mental illness and substance abuse. J Psychoact Drugs 1999; 31: 31–40
   PubMed Web of Science ®Google Scholar
• Moos R, Finney J, Federman E, Suchinsky R. Specialty mental health care improves patients' outcomes: findings from a nationwide program to monitor the quality of care for patients with substance use disorders. J Stud Alcohol 2000; 61: 704–13
   PubMed Web of Science ®Google Scholar
• Department of Health. Dual diagnosis in mental health inpatient and day hospital settings. Department of Health, London 2006
   Google Scholar
• Deans C, Soar R. Caring for clients with dual diagnosis in rural communities in Australia: the experience of mental health professionals. J Psychiatr Ment Health Nurs 2005; 12: 268–74
   PubMedGoogle Scholar
• Maslin J, Graham H, Cawley M, et al. Combined severe mental health and substance use problems: what are the training and support needs of staff working with this client group?. J Ment Health 2001; 10: 131–40
   Google Scholar
• Mears A, Clancy C, Banerjee S, Crome I, Agbo-Quaye S. Co-existing problems of mental disorder and substance misuse (dual diagnosis): a training needs analysis. Final report to the Department of Health. Royal College of Psychiatrists' Research Unit, London 2001
   Google Scholar
• Richmond I, Foster J. Negative attitudes towards people with co-morbid mental health and substance misusers problems: an investigation of mental health professionals. J Ment Health 2003; 12: 393–403
   Google Scholar